API | flomoxef

flomoxef (Flumarin) Report issue

Small molecule Experimental

AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW

Flomoxef is an oxacephem antibiotic that was developed by Shionogi. ^Wikipedia

Chemistry

SMILES: CO[C@]1(NC(=O)CSC(F)F)[C@H]2OCC(=C(N2C1=O)C(=O)O)CSc3nnnn3CCO
InChIKey: UHRBTBZOWWGKMK-DOMZBBRYSA-N
Mol. Mass: 496.47
ALogP: -1.29 Partition coefficient
ChEMBL Molecule:
flomoxef

More Chemistry

Pharmacology

Mechanism of Action:
- Cell division protein FtsI (Peptidoglycan synthetase) (Staphylococcus aureus) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

flomoxef | flomoxef sodium | oxacephem 6315-s | s 6315

Organizations (1)

Research & Development (1)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (2)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (2)

Bacterial Infections ()

Urinary Tract Infections (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 1
# of Trial Organizations: 1

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue